At ninety-two and in no hurry to die, a shipping patriarch still won't name an heir

The founder's office on Verne Station's inner ring has a window the length of a shuttle. Catch the shift change and you can watch the hulls his company carries take shape in the shipyard scaffolds below. Ildefons Arrázola has kept that office for sixty-one years. He has, by the account of three people who work down the corridor from him, no present intention of leaving it.

Arrázola is ninety-two. He runs Arrázola & Keel, a freight concern that clears roughly a fifth of the dry-cargo manifests between L5 and the Lunar Districts, and for the third year running he has declined to name a successor. The board meeting, held in the transfer-window lull when nobody is launching anything, adjourned last cycle with the succession item tabled again. (Tabled is generous. It was not taken up.)

"He is sharper than I was at sixty," said Mireia Keel-Arrázola, a grandniece who manages the Luna routes and is, for the record, sixty-three. "That is the problem, not the mitigation. You cannot wait out a man who has decided not to decline."

The medical facts are unremarkable now, which is exactly what makes them political. A seeded liver, a pair of lungs on file — routine, these days, the furniture of longevity. What's interesting is what routine lets a man postpone. For the past seven years Arrázola has run a slow-aging regimen licensed from one of the Meridian-adjacent institutes, administered through a clinic two rings over. It doesn't reverse anything. The chart tells a different story about what it actually buys him: not youth, just time, measured out in the currency of other people's patience. His physician, who spoke on condition that I not quote his labs, put the practical effect plainly — a man who might have handed over the firm at seventy on grounds of fatigue now simply is not fatigued.

A charter that never imagined this

Arrázola & Keel was chartered in Verne's early residential decades, back when the station was still proving it could hold air reliably. The founding document reads like the optimism of that era: generous on profit-sharing, meticulous on hull-maintenance obligations. On when a managing founder must step down, it says nothing. Not one word. The drafters didn't omit a retirement clause out of principle. The question never occurred to anyone writing rules for people who were going to predictably die.

"Every old charter has this hole in it," said Toussaint Okiro, who studies founding instruments at the Archive of the Recovery and has catalogued forty-odd settlement firms with the same gap. "They assumed mortality would do the pruning. It was the cheapest governance mechanism ever devised, and it was free, and now it's gone, and nobody budgeted for the replacement."

A bloc of four cousins — all between sixty and seventy, all of whom entered the firm expecting to run it — has petitioned the board to insert a mandatory-retirement clause, age-indexed, with a grace period. It reads like a document written by people who did the math and didn't like the answer. If Arrázola serves another twenty years, which his regimen makes entirely plausible, the eldest petitioner will be eighty-three before the office opens, and will arrive carrying the same therapies and the same disinclination to leave it. The door doesn't open once. It stops opening.

Arrázola declined an interview but sent, through his office, a two-line note.

"The firm has no rule requiring my retirement, and I have found no argument requiring it either. When I am no longer useful, that will be evident, and I will be the first to see it."

I've read a great many prognoses written by patients about themselves. They are, as a genre, the least reliable in medicine. This one at least has the decency to be honest about its self-interest.

The quiet version of the fight

This is the Charter Court's problem in miniature, playing out in one household without the dignity of a courtroom. The Court is weighing whether colonies can bind their grandchildren. Arrázola & Keel is weighing whether a grandniece will ever manage anything larger than the Luna routes. The stakes scale down. The mechanism doesn't change at all — an instrument written for mortals, operated by people who have quietly opted out of the assumption.

The cousins' petition goes to a board vote in two transfer windows. Four of the seven directors are over eighty. None of them, a staffer noted, is on a schedule to leave either.

Mireia Keel-Arrázola has stopped describing it as a succession. "It isn't a line anymore," she said. "A line moves. This is a room with one chair and very good furniture, and the man in it has grown a new liver." She said she would vote for the clause. She said she did not expect it to pass. Down in the scaffolds, the shift changed, and another hull went on carrying his name.